Mercury Biopharmaceutical (ROCO:6932) Inventory-to-Revenue : 0.00 (As of Jun. 2024)

---

Mercury Biopharmaceutical Inventory-to-Revenue Chart

---

Competitive Comparison of Mercury Biopharmaceutical's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Mercury Biopharmaceutical's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

---

Mercury Biopharmaceutical's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mercury Biopharmaceutical's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Mercury Biopharmaceutical's Inventory-to-Revenue falls into.

---

Mercury Biopharmaceutical Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Mercury Biopharmaceutical's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Mercury Biopharmaceutical's Inventory-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

---

Mercury Biopharmaceutical  (ROCO:6932) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Mercury Biopharmaceutical's Days Inventory for the six months ended in Jun. 2024 is calculated as:

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Mercury Biopharmaceutical's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

---

Mercury Biopharmaceutical Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mercury Biopharmaceutical's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Total Inventories Revenue Days Inventory Cost of Goods Sold Inventory Turnover

---

Mercury Biopharmaceutical Business Description